SCHEMBL8889871

SCHEMBL8889871

COc1ccc2oc(C)c(Cc3cccc(NS(=O)(=O)C(F)(F)F)c3)c(=O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 6/20 0.42
▸ MTNR1A P48039 3/20 0.42
▸ MTNR1B P49286 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ RAF1 P04049 5/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ VKORC1 Q9BQB6 1/20 0.40
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8889154 0.87 ACP1 (0.41) MAP2K1KDM4ERAF1CYP3A4CYP2C9
SCHEMBL8888992 0.80 CYSLTR1 (0.58) MAP2K1
SCHEMBL14689917 0.71 PTGS1 (0.63) ALDH1A1HPGDSMN1; SMN2PTGS1PTGS2
SCHEMBL8623799 0.70 MAPT (0.45) MTNR1AMTNR1BKDM4EALDH1A1SMN1; SMN2
SCHEMBL6474786 0.67 LTB4R (0.41) PTGS1PTGS2
SCHEMBL8889873 0.66 CYP3A4 (0.49) KDM4EALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL19567186 0.66 PTGS1 (0.63) SMN1; SMN2MAPTPTGS1PTGS2
SCHEMBL8889251 0.66 CYSLTR1 (0.38) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL6479426 0.65 KDM1A (0.43) PTGS1PTGS2
SCHEMBL8888125 0.65 CYP19A1 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5641789-A INHIBITORS OF LEUKOTRIENES AND/OR BLOCKERS OF LEUKOTRIENE RECEPTORS; USEFUL IN PREVENTION OR TREATMENT OF ASTHMA, ARTHRITIS, PSORIASIS, ULCERS, MYOCARDIAL INFARCTION PFIZER INC. (US) 1997-06-24 — — US disclosed
EP-0665842-A1 SULFONAMIDE DERIVATIVES OF BENZENEFUSED HYDROXY SUBSTITUTED CYCLOALKYL AND HETEROCYCLIC RING COMPOUNDS PFIZER INC. (US) 1995-08-09 — — EP disclosed
WO-1994008996-A1 SULFONAMIDE DERIVATIVES OF BENZENEFUSED HYDROXY SUBSTITUTED CYCLOALKYL AND HETEROCYCLIC RING COMPOUNDS PFIZER INC. (US) 1994-04-28 — — WO disclosed
Send feedback